Clinical Case Reports (Jul 2021)

Methotrexate monotherapy for unilateral moderately active thyroid‐related eye disease

  • Ayman G. Elnahry,
  • Joseph H. Talbet,
  • Gehad A. Elnahry

DOI
https://doi.org/10.1002/ccr3.4559
Journal volume & issue
Vol. 9, no. 7
pp. n/a – n/a

Abstract

Read online

Abstract A type 1 diabetic patient with unilateral active thyroid‐related eye disease was intolerant to systemic steroid therapy due to uncontrollable blood sugar levels. She was treated with low‐dose methotrexate monotherapy, which resulted in a marked improvement of her condition with no adverse events.

Keywords